Infectious DiseaseS

A wealth of testing experience

Mayo Clinic BioPharma Diagnostics offers access to the clinical trial infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the bacterial, viral, fungal, and parasitic agents of infectious diseases.

Performing more than four million tests annually, our seven clinical microbiology laboratories have developed and implemented in vitro and culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization of microbial pathogens.

Our molecular testing methods include:

  • Polymerase chain reaction (PCR) testing
  • Advanced whole genome microbial sequencing
  • Targeted metagenomic sequencing
  • Matrix-assisted laser-desorption/ionization-time of flight (MALDI-TOF) mass spectrometry organism identification

Physician-led subspecialized laboratories

Our laboratories are managed by physician-scientists, many of whom are actively engaged in clinical practice and research. Through BioPharma Diagnostics, our partners have access to a wealth of world-renowned expertise to help guide test ordering and interpret results.

Infectious disease test menu

Through BioPharma Diagnostics, our partners have access to Mayo Clinic Laboratories’ infectious disease test catalog, including testing for:

  • SARS-CoV-2
  • Helicobacter pylori
  • Infectious disease pathology
  • Vector-borne diseases
  • HIV and hepatitis

In addition to using clinically available testing, BioPharma Diagnostics partners can access infectious disease testing for clinical trials and be among the first to use up-and-coming tests currently in development.

Learn more about how we can work together.